- AU$18.90m
- AU$18.54m
- AU$8.90m
- 26
- 81
- 22
- 42
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.93 | 7.28 | 2.52 | 3.67 | 8.9 |
Cost of Revenue | |||||
Gross Profit | 2.63 | 2.84 | -0.986 | 1.48 | 3.86 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8.81 | 9.74 | 4.96 | 7.86 | 11.5 |
Operating Profit | -2.88 | -2.46 | -2.44 | -4.19 | -2.64 |
Net Income Before Taxes | -2.88 | -2.46 | -2.44 | -4.19 | -2.64 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.88 | -2.46 | -2.44 | -4.19 | -2.64 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.88 | -2.46 | -2.44 | -4.19 | -2.64 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.88 | -2.46 | -2.44 | -4.19 | -2.64 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.011 | -0.008 | -0.006 | -0.008 | -0.004 |